1146849

Michael J. Downing, M.D. — FEI 3014256731

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 15, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)